Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
US Pork Giant Smithfield Foods Raises $522M After Pricing IPO Below Range
Smithfield Foods and its Chinese parent raised around $522 million from the U.S. pork giant's initial public offering after ...
Northpointe Bancshares Begins $201 Million IPO Effort
Northpointe Bancshares plans $201.25M IPO for retail banking, residential lending, and digital deposit banking. Explore more ...
Infinity Natural valued at $1.3 billion in debut as US energy IPOs rebound
Infinity Natural Resources was valued at $1.30 billion after its shares jumped nearly 11% in their NYSE debut on Friday, ...
Cement Producer Titan America Seeks up to $3.3 Billion Valuation in US IPO
(Reuters) - Titan America is seeking a valuation of up to $3.32 billion in its New York initial public offering, the ...
WBEZ7h
White activists sue Bally’s over Chicago casino IPO limited to women, minorities
Bally's announced a $250 million public offering last month for shares of its massive Chicago casino project, but only to ...
Drug developer Maze Therapeutics eyes up to $728 million valuation in US IPO
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...
Titan America Sets IPO Terms That Could Push Market Cap Above $3 Billion
Titan America, which makes heavy building materials and operates primarily on the U.S. Eastern Seaboard, on Tuesday said it plans to sell 9 million shares at between $15 and $18 apiece in the IPO, for ...
Karman Holdings Aims High With $100 Million US IPO Plan
Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...
Upstream3d
What Venture Global’s IPO means for its founders' net worth — and for the company
Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...
J&J-Backed Medtech Firm HistoSonics Considers US IPO
HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...
Biocon Biologics plans IPO for biosimilars business by Mar 2026: CEO
The company, which has been pushing its IPO plans for the past year, has been waiting to complete the integration of its acquired biosimilars firm Viatris and refinance debt before it goes public ...